CSIMarket
 




Royalty Pharma Plc  (RPRX)
Other Ticker:  
 
 



RPRX Price to Earnings Ratio (Dec 31 2023) (Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Diluted EPS 12 Trailing Months IV. Quarter III. Quarter II. Quarter I. Quarter IV. Quarter
PE (TTM) Ratio current            13.40            42.61            38.93            35.15            105.17
Diluted EPS TTM Y / Y Change 480.13 % -41.99 % -22.75 % -29.19 % -74.3 %
Diluted EPS Y / Y Change - % -50 % -28.57 % 533.33 % - %
Stock performance to date 11.02 % -13.04 % -11.18 % -9.64 % -7.18 %

Price to earnings ratio Comment
Despite shareprice increase of 11.02 %, from beginning of IV. Quarter Royalty Pharma Plc's current Price to earnings ratio has contracted due to eps growth of 0 %, to Pe of 13.40, from average Price to earnings ratio in III. Quarter of 42.61.

Within Healthcare sector 3 other companies have lower Price to earnings ratio.

What is Price to Earnings Ratio?
What is Royalty Pharma Plc Market Share?

Price to earnings ratio Company Ranking
Within: No.
Industry #2
Sector #4
S&P 500 #119







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com